Capital Advisors Ltd’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $21K | Hold |
48
| – | – | ﹤0.01% | 619 |
|
2025
Q1 | $23K | Buy |
48
+17
| +55% | +$8.15K | ﹤0.01% | 596 |
|
2024
Q4 | $12K | Sell |
31
-3
| -9% | -$1.16K | ﹤0.01% | 749 |
|
2024
Q3 | $16K | Hold |
34
| – | – | ﹤0.01% | 662 |
|
2024
Q2 | $16K | Sell |
34
-2
| -6% | -$941 | ﹤0.01% | 639 |
|
2024
Q1 | $15K | Buy |
36
+6
| +20% | +$2.5K | ﹤0.01% | 645 |
|
2023
Q4 | $12K | Hold |
30
| – | – | ﹤0.01% | 670 |
|
2023
Q3 | $10K | Sell |
30
-1
| -3% | -$333 | ﹤0.01% | 692 |
|
2023
Q2 | $11K | Hold |
31
| – | – | ﹤0.01% | 688 |
|
2023
Q1 | $10K | Buy |
31
+9
| +41% | +$2.9K | ﹤0.01% | 567 |
|
2022
Q4 | $6K | Hold |
22
| – | – | ﹤0.01% | 639 |
|
2022
Q3 | $6K | Hold |
22
| – | – | ﹤0.01% | 613 |
|
2022
Q2 | $6K | Buy |
22
+13
| +144% | +$3.55K | ﹤0.01% | 561 |
|
2022
Q1 | $2K | Buy |
9
+6
| +200% | +$1.33K | ﹤0.01% | 657 |
|
2021
Q4 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 761 |
|